Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04405570
Recruitment Status : Completed
First Posted : May 28, 2020
Last Update Posted : February 23, 2021
Sponsor:
Information provided by (Responsible Party):
Ridgeback Biotherapeutics, LP